arrow
V

Valentina Mercurio

Federico II University of Naples
H指数:31
被引数:3,273

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Predicting the reduction of functional mitral regurgitation with optimized medical therapy in HFrEF patients by standard echocardiography and non-invasive pressure–volume loop model

通过标准超声心动图和非侵入性压力-容积环模型预测HFrEF患者优化药物治疗下功能性二尖瓣反流的减少

2026-09-300
PRE
The Transition from Stage A to Stage B of Heart Failure: Risk Factors, Promoting Factors, and Opportunities for Prevention—An Update from the Italian Society of Cardiology Working Group on Heart Failure

从心衰A期到B期的转变:风险因素、促进因素及预防机会——意大利心脏病学会心力衰竭工作组最新报告

2026-09-090
PRE
Bidirectional impact between cardiovascular comorbidities and heart failure: an updated position paper from the Italian society of cardiology (SIC) working group on heart failure

心血管合并症与心力衰竭的双向影响:意大利心脏病学会(SIC)心力衰竭工作组更新的立场文件

2026-08-310
PRE
Pulmonary arterial hypertension: right ventricular phenotyping to improve risk assessment at follow-up

肺动脉高压:右心室表型分析以改善随访风险评估

2026-02-011
PRE
The activin pathway in chronic thromboembolic pulmonary hypertension: a potential biomarker for residual pulmonary hypertension after endarterectomy

慢性血栓栓塞性肺动脉高压中的激活素途径: 动脉内膜切除术后残余肺动脉高压的潜在生物标志物

2025-11-030
PRE
Pathophysiology of Pulmonary Arterial Hypertension: Focus on Vascular Endothelium as a Potential Therapeutic Target

肺动脉高压的病理生理学:聚焦血管内皮作为潜在治疗靶点

2025-10-020
OAAI
Advanced Echocardiographic Assessment Predicts 1-Year Mortality in Critically Ill Patients With Pulmonary Arterial Hypertension

高级超声心动图评估可预测肺动脉高压危重患者的1年死亡率

2025-10-010
OAAI
Non cardiovascular comorbidities in Heart Failure. An updated position paper from the Heart Failure Working Group of the Italian Society of Cardiology (SIC)

心力衰竭中的非心血管合并症。意大利心脏病学会(SIC)心力衰竭工作组发布的一份更新立场文件

2025-08-190
PRE
Cardio-Oncology Challenges in Elderly Patients

老年患者的心脏肿瘤学挑战

2025-05-070
OA
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults and Special Considerations in Pulmonary Hypertension: Recommendations from the American Society of Echocardiography
2025-03-010
PRE
The effects of Dapagliflozin in a real-world population of HFrEF patients with different hemodynamic profiles: worse is better
2024-11-221
OAAI